exRNAdisease

Entry Detail

---



General Information

Database ID: exR0093376 RNA Name: hsa-miR-302c-3p RNA Type: miRNA Chromosome: chr4 Starnd: - Coordinate: Start Site(bp): 112648366 End Site(bp): 112648388 External Links: hsa-miR-302c-3p

Disease Information

Disease Name: Benign Ovarian Disease Disease Category: Urogenital Diseases and Pregnancy Complications MeSH ID: D010049 Type: Diseases Category/Female Urogenital Diseases and Pregnancy Complications Alias: Ovarian Diseases//Disease, Ovarian//Diseases, Ovarian//Ovarian Disease

Expression Detail

GEO ID: GSE106817 Description: Integrated extracellular microRNA profiling for ovarian cancer screening Experimental Design: Cancer vs Control Case Disease Type: Benign Ovarian Disease Case Disease SubType: NA Case Sample: Benign Ovarian Disease Control Sample: Non-Cancer Number of Case: 29 Number of Control: 2759 Number of Samples: 2788

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand MTMR12 chr5 32226994 32312987 - TXNIP chr1 145992435 145996579 - CLU chr8 27596917 27614700 - MBP chr18 76978827 77133683 - CCNB1 chr5 69167135 69178245 + SETD7 chr4 139495941 139606699 - NUP153 chr6 17615035 17706834 - SEC16A chr9 136440096 136483759 - SLAIN2 chr4 48341529 48426201 + ZSCAN26 chr6 28267010 28278224 + CUL1 chr7 148697914 148801110 + TRA2A chr7 23504780 23532041 - TEFM chr17 30897336 30906238 - CCNG2 chr4 77157207 77433388 + CDK6 chr7 92604921 92836594 - FYCO1 chr3 45917899 45995824 - PSMD5 chr9 120815496 120842951 - MTFR2 chr6 136231024 136250335 - VRK1 chr14 96797382 96931722 + UGP2 chr2 63840940 63891562 + KMT5B chr11 68154863 68213828 - SEMA3C chr7 80742538 80922359 - COX7C chr5 86617928 86620962 + SRRT chr7 100875103 100888664 + BCL7A chr12 122019422 122062044 + PDXK chr21 43719094 43762307 + MOB1A chr2 74152528 74178898 - MSTO1 chr1 155610188 155614971 + NPC2 chr14 74476192 74494177 - CAMK2N1 chr1 20482391 20486210 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000943 chr19 47421744 47440665 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC011503.2 chr19 23927788 23929287 + AC125257.1 chr17 41848518 41851447 - AL049840.4 chr14 103694516 103695050 - ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - FGD5-AS1 chr3 14920347 14948424 - MIR17HG chr13 91347820 91354579 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE106817 Sample Source: Blood Source Fraction: Serum Platform: GPL21263 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2535 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.). RNA library preparation protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

Reference

PMID: 30333487 Title: Integrated extracellular microRNA profiling for ovarian cancer screening Author: Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T Journal: Nat Commun. 2018 Oct 17;9(1):4319. Description: to develop an optimal detection method, we use microarrays to obtain comprehensive miRNA profiles from 4046 serum samples, including 428 patients with ovarian tumors.